| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 09/16/2004 | WO2004078922A2 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 09/16/2004 | WO2004078919A2 Superactive cellulase formulation using cellobiohydrolase-1 from penicillium funiculosum |
| 09/16/2004 | WO2004078914A2 A fluorinase enzyme and use thereof in fluorination synthesis |
| 09/16/2004 | WO2004078912A2 Chicken rna polymerase i promoter and the use thereof |
| 09/16/2004 | WO2004078910A2 Identifying inhibitors of type ii isopentenyl diphosphate: dimethylallyl diphosphate isomerase |
| 09/16/2004 | WO2004078773A1 Stabilizing proteins for use in personal care, cosmetic, and pharmaceutical products |
| 09/16/2004 | WO2004078215A2 Use of antibody conjugated deoxycytidine kinase for adept |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078130A2 Posh interacting proteins and related methods |
| 09/16/2004 | WO2004072225A3 Transgenic fungi expressing bcl-2 and methods of using bcl-2 or portions thereof for improving biomass production, survival, longevity, stress resistance and pathogenicity of fungi |
| 09/16/2004 | WO2004067753A3 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof. |
| 09/16/2004 | WO2004065606A3 Glycerol kinase inhibition in transgenic plant cells |
| 09/16/2004 | WO2004065593B1 Recombinant bovine pepsin and pepsinogen produced in prokaryotic and eukaryotic cells |
| 09/16/2004 | WO2004065333A3 Organic, metallorganic and biological material obtained from rock |
| 09/16/2004 | WO2004062627A9 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004061116A3 Compositions and methods for hydroxilating epothilones |
| 09/16/2004 | WO2004056982A3 Kinase sequences |
| 09/16/2004 | WO2004053116A3 Polynucleotides targeted against htert and use thereof |
| 09/16/2004 | WO2004053089A3 Improved methods and materials for reducing production of aberrant products during rna synthesis |
| 09/16/2004 | WO2004048544A3 Ca ix-specific inhibitors |
| 09/16/2004 | WO2004037973A3 Zymomonas pentose-sugar fermentating strains and uses thereof |
| 09/16/2004 | WO2004027018A3 Inducible focal adhesion kinase cell assay |
| 09/16/2004 | WO2003106658A3 Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter |
| 09/16/2004 | WO2003102160A3 Rationally designed polysaccharide lyases derived from chondroitinase b |
| 09/16/2004 | WO2003095615A3 Transgenic plants with a suppressed triterpene level |
| 09/16/2004 | WO2003070746A3 Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua |
| 09/16/2004 | WO2003062265A3 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 09/16/2004 | WO2003060063A3 Hyaluronan synthase genes and expression thereof |
| 09/16/2004 | WO2003046130A3 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics |
| 09/16/2004 | WO2003014368A3 Use of xylene monooxygenase for the oxidation of substituted monocyclic aromatic compounds |
| 09/16/2004 | WO2002090492A3 Fungal chitinases, polynucleotide sequences encoding same, promoters of same, and uses thereof |
| 09/16/2004 | WO2002062948A3 25828, a novel human aminopeptidase and uses therefor |
| 09/16/2004 | US20040181829 for mitogen-activated protein kinase kinase kinase (MAPKKK) in mono/dicotyledons; genetic engineering |
| 09/16/2004 | US20040181827 Plant Gntl sequences and the use thereof for the production of plants having reduced or lacking N-acetyl glucosaminyl transferase I (GnTI) activity |
| 09/16/2004 | US20040181824 for modulating, in a transgenic plant, expression of the nucleic acids and for increasing transformation efficiency; genetic engineering |
| 09/16/2004 | US20040181823 produced in genetically engineered plants and seeds |
| 09/16/2004 | US20040181041 Fusion protein capable of inducing programmed cell death for use in treatment cell proliferative diseases and infection |
| 09/16/2004 | US20040181038 Comprises 3-oxoacyl-[acyl-carrier-protein] synthase III for use in identifying modulator for preventing microorganismal infections |
| 09/16/2004 | US20040180927 Inhibitors of cysteine protease |
| 09/16/2004 | US20040180847 Inhibiting synthesis and function; arresting cellular proliferation |
| 09/16/2004 | US20040180845 Methods and compositions for modulating glycogen synthesis and breakdown |
| 09/16/2004 | US20040180828 Apoptosis suppression; polypeptides of sequence 2 having surface groove including amino acid residues P325, G326, H343 and L344 |
| 09/16/2004 | US20040180813 4-Amino acid functionalized-2-pyrophosphatyl-pyranes; direct assay, high throughput screening for enzyme inhibitors; N-acetylglucosaminyltransferase |
| 09/16/2004 | US20040180439 Expression vector comprising promoter elements and which codes complimentary nucleotide sequences of preferential genes for use as therapeutic tool in targeted tissue/cell therapy; gene expression inhibition |
| 09/16/2004 | US20040180433 Methods of using mammalian RNase H and compositions thereof |
| 09/16/2004 | US20040180419 by combining protein replacement therapy with active site-specific chaperones (ASSC) to increase the stability and efficiency of the protein being administered |
| 09/16/2004 | US20040180418 Candida kefyr cytosine deaminase |
| 09/16/2004 | US20040180417 Secretase/sheddase with asp-ase activity on the beta-site app-cleaving enzyme (bace, asp2, memepsin2) |
| 09/16/2004 | US20040180416 Comprises nucleotide sequences coding serine-threonine and/or carbon catabolite depressing kinases for use in nutraceuticals and treating metabolic disorders; pharmacogenomics |
| 09/16/2004 | US20040180413 Method for producing ascorbic acid intermediates |
| 09/16/2004 | US20040180410 Expression vector coding camel proteolytic enzyme for expression in milk products; food processing and cheese manufacturing |
| 09/16/2004 | US20040180408 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 09/16/2004 | US20040180406 Nucleic acids encoding sialytransferases from C. jejuni |
| 09/16/2004 | US20040180400 Carboxylic acid reductase polypeptide, nucleotide sequence encoding same and methods of use |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |
| 09/16/2004 | US20040180386 Using major histocompatibility complex polypeptides as tools in identifying lymphocyte binding sites; immunosuppression and tumor therapeutics |
| 09/16/2004 | US20040180356 Comprises nucleotide sequences coding membrane proteins for use in diagnosis, prevention and treatment of cell proliferative, metabolic and inflammatory disorders |
| 09/16/2004 | US20040180354 Comprises polypeptides which are displayable on antigen presenting cells of immune system for use in prevention and treatment of infection and vaccine development; immunotherapy |
| 09/16/2004 | US20040180348 Method for surface display of proteins of genetic carriers |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | US20040180337 Human extracellular signal regulated kinases |
| 09/16/2004 | DE10309580A1 Identifizierung von Inhibitoren der Typ II-Isopentenyldiphosphat: Dimethylallyldiphosphat-Isomerase Identifying inhibitors of type II isopentenyl diphosphate: dimethylallyl diphosphate isomerase |
| 09/16/2004 | DE10309169A1 Rekombinante, FAD-abhängige Sulfhydryloxidasen, Verfahren zu deren Herstellung und deren Verwendung Recombinant FAD-dependent Sulfhydryloxidasen, processes for their preparation and their use |
| 09/16/2004 | CA2518402A1 Process for producing lactonase and utilization thereof |
| 09/16/2004 | CA2518400A1 Transgenic plants modified to accumulate fructooligosaccharides and production thereof |
| 09/16/2004 | CA2518094A1 Anaplastic lymphoma kinase assay, reagents and compositions thereof |
| 09/16/2004 | CA2517879A1 Enhanced amylose production in plants |
| 09/16/2004 | CA2517857A1 Methods for preventing gluconoylation of proteins |
| 09/16/2004 | CA2517525A1 Posh interacting proteins and related methods |
| 09/16/2004 | CA2517375A1 Chicken rna polymerisate i promoter and the use thereof |
| 09/16/2004 | CA2517145A1 Soluble hyaluronidase glycoprotein (shasegp), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 09/16/2004 | CA2517101A1 A modified oligonucleotide for inhibition of growth hormone receptor expression |
| 09/16/2004 | CA2514730A1 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements |
| 09/15/2004 | EP1457563A1 Regulation of quinolate phosphoribosyl transferase expression |
| 09/15/2004 | EP1457562A1 Regulation of quinolate phosphorribosyl transferase expression |
| 09/15/2004 | EP1457561A1 Biosynthetic genes of blakeslea trispora beta-carotene that code for lycopene cyclase/phytoene synthase (carrp) and phytoene dehydrogenase (carb) |
| 09/15/2004 | EP1457560A1 High-activity phytase compositions |
| 09/15/2004 | EP1457554A1 Process for producing biodegradable polyester |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456400A2 Modulating insulin receptor signaling through targeting facl |
| 09/15/2004 | EP1456394A2 Methods of using improved polymerases |
| 09/15/2004 | EP1456384A2 Novel alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456370A2 Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
| 09/15/2004 | EP1456369A1 Polypeptides having protease activity and nucleic acids encoding same |
| 09/15/2004 | EP1456368A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456367A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 09/15/2004 | EP1456366A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 09/15/2004 | EP1456365A2 Protein modification and maintenance molecules |
| 09/15/2004 | EP1456364A2 Mutations in the b-raf gene |
| 09/15/2004 | EP1456363A1 Alleles of the siga gene from coryneform bacteria |
| 09/15/2004 | EP1456362A2 Method for the generation of proteins with new enzymatic function |
| 09/15/2004 | EP1456361A2 Process for harvesting crystalline particles from fermentation broth |
| 09/15/2004 | EP1456360A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
| 09/15/2004 | EP1456349A2 Expression system |
| 09/15/2004 | EP1456228A2 Method of isolation and purification of trypsin from pronase and use thereof |
| 09/15/2004 | EP1456220A2 Thermus thermophilus nucleic acid polymerases |
| 09/15/2004 | EP1455815A2 Human diacylglycerol acyltransferase 2 (dgat2)family members and uses therefor |